 On January 1, 2011, he became CEO and a member of the company's board of directors, replacing former Merck & Co. CEO Richard Clark.Frazier is the first African-American to lead a major pharmaceutical company.As CEO, Frazier has directed the company to take financial risks in developing new treatments.